Amlodipine besylate and Aminobenzoic acid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Amlodipine besylate and Aminobenzoic acid. Common interactions include anxiety among males.

The phase IV clinical study analyzes what interactions people who take Amlodipine besylate and Aminobenzoic acid have. It is created by eHealthMe based on reports of 11 people who take Amlodipine besylate and Aminobenzoic acid from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 03, 2022

11 people who take Amlodipine besylate and Aminobenzoic acid together, and have interactions are studied.


What is Amlodipine besylate?

Amlodipine besylate has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 56,828 Amlodipine besylate users for its effectiveness, alternative drugs and more.

What is Aminobenzoic acid?

Aminobenzoic acid has active ingredients of para - aminobenzoic acid (paba). eHealthMe is studying from 241 Aminobenzoic acid users for its effectiveness, alternative drugs and more.

Number of Amlodipine besylate and Aminobenzoic acid reports submitted per year:

Amlodipine besylate and Aminobenzoic acid drug interactions.

Common Amlodipine Besylate and Aminobenzoic Acid drug interactions by gender *:

female:

n/a

male:

  1. Anxiety
  2. Ataxia
  3. Hypertonic bladder
  4. Hypoaesthesia
  5. Insomnia
  6. Memory impairment
  7. Micturition urgency
  8. Monoparesis
  9. Movement disorder
  10. Multiple sclerosis relapse

Common Amlodipine Besylate and Aminobenzoic Acid drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anxiety
  2. Ataxia
  3. Balance disorder
  4. Bradycardia
  5. Central nervous system lesion
  6. Dizziness
  7. Dysarthria
  8. Erectile dysfunction
  9. Fall
  10. Gait spastic

50-59:

  1. Anxiety
  2. Ataxia
  3. Hypertonic bladder
  4. Hypoaesthesia
  5. Insomnia
  6. Memory impairment
  7. Micturition urgency
  8. Monoparesis
  9. Movement disorder
  10. Multiple sclerosis relapse

60+:

n/a

Common conditions people have *:

  1. Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 10 people, 90.91%
  2. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Amlodipine besylate and Aminobenzoic acid?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Amlodipine besylate and Aminobenzoic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Amlodipine besylate interactions:

Browse all interactions between Amlodipine besylate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Aminobenzoic acid interactions:

Browse all interactions between Aminobenzoic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate and para - aminobenzoic acid (paba) (the active ingredients of Amlodipine besylate and Aminobenzoic acid, respectively), and Amlodipine besylate and Aminobenzoic acid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Amlodipine besylate and Aminobenzoic acid.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: